Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression - AJMC.com Managed Markets Network

Submitted by Anonymous (not verified) on Tue, 01/21/2025 - 16:00

Esketamine Approved by FDA as First Monotherapy for Treatment-Resistent Depression  AJMC.com Managed Markets Network